IPUT has secured a trio of new tenants for its redeveloped Earlsfort Terrace office scheme in Dublin taking a total of 40,000 sq ft between them.
In the lead letting, IPUT, alongside joint venture partner Cashel Fund, have let 26,000 sq ft of space to NASDAQ-listed US biotechnology company BioMarin Pharmaceuticals. The $2.8bn pharmaceutical giant, which is a global leader in enzyme replacement therapies (ERTs), will occupy the fourth, fifth and sixth floors of the city centre office building.
You must be logged in to view premium stories.
Take out a print and online or online only subscription and you will get immediate access to:
To get access to premium content subscribe today
Alternatively REGISTER for a free trial to access up to 4 articles and sign up for email alerts